VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

The effect of pyrazidole on monoamine level in hypobaric hypoxia

   
Goroshinskaia I.A., Nemashkalova L.A., Khodakova A.A., Sorokina I.V.
PubMed Id: 8122400
Year: 1994  Volume: 40  Issue: 1  Pages: 16-18
Increase of serotonin content and decrease in 5-hydroxyindolyl acetic acid (5-HIAA) were observed under hypoxic conditions (9,000 m, 3 hrs) which correlated with inhibition of monoamine oxidase A. Administration of the monoamine oxidase inhibitor pyrazidole caused the more pronounced increase of serotonin levels and decrease of 5-HIAA in control animals as well as in hypoxic animals. The catecholamines increased in hypoxia, pretreatment with pyrazidole prevented this increase. Preliminary administration of pyrazidole also increased the content of blood catecholamines, which reduced in hypoxia. Pyrazidole exhibited the antistress effect as the drug inhibited a decrease in adrenal ascorbic acid levels in hypoxic conditions.
Download PDF:  
Citation:

Goroshinskaia, I. A., Nemashkalova, L. A., Khodakova, A. A., Sorokina, I. V. (1994). The effect of pyrazidole on monoamine level in hypobaric hypoxia. Voprosy Meditsinskoi Khimii, 40(1), 16-18.
References
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)